从1999年开始，马来酸罗格列酮和盐酸匹格列酮被批准使用。
Beginning in 1999, rosiglitazone maleate and pioglitazone hydrochloride were approved for use.
目的观察马来酸罗格列酮（商品名文迪雅）与胰岛素合用治疗2型糖尿病（T 2DM）的临床疗效和安全性。
OBJECTIVE To observe the clinical therapeutic effects and safety in the treatment of type 2 diabetes mellitus(T2DM) with Avandia and Insulin.
目的观察马来酸罗格列酮（商品名文迪雅）与胰岛素合用治疗2型糖尿病（T 2DM）的临床疗效和安全性。
OBJECTIVE To observe the clinical therapeutic effects and safety in the treatment of type 2 diabetes mellitus(T2DM) with Avandia and Insulin.
应用推荐